Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

sinkingfeeling

(51,444 posts)
Fri Apr 13, 2018, 11:53 AM Apr 2018

"Is curing patients a sustainable business model?" Goldman Sachs analysts ask

https://arstechnica.com/tech-policy/2018/04/curing-disease-not-a-sustainable-business-model-goldman-sachs-analysts-say/?amp=1&__twitter_impression=true

One-shot cures for diseases are not great for business—more specifically, they’re bad for longterm profits—Goldman Sachs analysts noted in an April 10 report for biotech clients, first reported by CNBC.

The potential to deliver “one shot cures” is one of the most attractive aspects of gene therapy, genetically engineered cell therapy, and gene editing. However, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies... While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow.


More at link on how the creepiest amongst us think.
16 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies

shraby

(21,946 posts)
2. I've suspected that was the game plan for years. Curing a disease cuts off the revenue.
Fri Apr 13, 2018, 11:56 AM
Apr 2018

Treating ad infinitum is very profitable indeed.

Girard442

(6,066 posts)
3. If that kind of thinking were carried to the max...
Fri Apr 13, 2018, 11:56 AM
Apr 2018

...the drug companies would be churning out tons products that it would be nearly impossibe to stop taking. But they wouldn't do that, right?

 

oberliner

(58,724 posts)
5. It's definitely not
Fri Apr 13, 2018, 11:57 AM
Apr 2018

Much better to provide a medication that they have to take for the rest of their lives.

fleur-de-lisa

(14,624 posts)
6. No worries. They'll just charge $500,000 for one-shot cures.
Fri Apr 13, 2018, 11:57 AM
Apr 2018

Those of us who cannot afford it can just fuck off and die.

Farmer-Rick

(10,150 posts)
12. Yup, capitalism at it's finest...err worst
Fri Apr 13, 2018, 12:27 PM
Apr 2018

In a way, all doctors and pharmaceutical corporations are abject failures because they have yet to cure death.

The whole purpose of seeing doctors and taking medicine is to put off dying for a little while longer. But in the end we all die and doctors and pharmaceutical corporations are total failures. Just think how much money they could get from us if they kept us alive forever.

c-rational

(2,590 posts)
10. Prevention is the best answer...better than a one shot cure. I recommend the movie "What The
Fri Apr 13, 2018, 12:13 PM
Apr 2018

Health" on Netflicks.

 

Hoyt

(54,770 posts)
11. I think that depends on how much the "one shot cure" costs and whether people can afford it,
Fri Apr 13, 2018, 12:20 PM
Apr 2018

whether paying out-of-pocket, through an insurance company, or through single payer if we ever get there.

I guarantee a "one shot cure" for diabetes or cancer would be worth trillions. Not sure that will ever be accomplished, but the cure would be worth a ton, especially in terms of lives saved and savings in future health care expenditures.

unblock

(52,164 posts)
14. The *analysis* isn't the problem.
Fri Apr 13, 2018, 12:30 PM
Apr 2018

It is what it is given the system we have. Really, this is just explaining the situation.

The problem lies in the ethical and policy conclusions. Do we alter our system to encourage long-term cures? Or do we deem it acceptable for health businesses to seek less-effective but more profitable treatments?

It's what we do with this sort of analysis that matters.

Latest Discussions»General Discussion»"Is curing patients a sus...